Utama › Melanoma › New Jersey › Edison
Kajian klinikal Melanoma di Edison, NJ
15 kajian untuk Melanoma sedang mencari peserta di lokasi dalam dan sekitar Edison (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- START New Jersey, East Brunswick · 6 mi jauh
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Mengambil pesertaFasa 3
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Mengambil pesertaFasa 3
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
A Pilot Study of ctDNA-Guided Immune Checkpoint Inhibitor Duration in Patients With Advanced Melanoma.
Mengambil peserta
- Rutgers Cancer Institute, New Brunswick · 3 mi jauh
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Mengambil pesertaKajian pemerhatian
- Astera Cancer Care, East Brunswick · 6 mi jauh
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Mengambil peserta
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauh
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Mengambil pesertaFasa 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
Project: Every Child for Younger Patients With Cancer
Mengambil pesertaKajian pemerhatian
- Saint Peter's University Hospital, New Brunswick · 3 mi jauh
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi jauh
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauh
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
Mengambil peserta
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Mengambil pesertaFasa 3
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Mengambil pesertaFasa 3
- Rutgers Cancer Institute, 195 Little Albany Street, New Brunswick · 3 mi jauh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, New Brunswick · 3 mi jauh
Naltrexone and Propranolol Combined With Immunotherapy
Mengambil pesertaFasa 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Mengambil peserta
- Rutgers Cancer Institute of New Jersey, Piscataway · 2 mi jauh
Kajian Melanoma di bandar lain
- Houston, TX59 kajian
- New York City, NY38 kajian
- Los Angeles, CA34 kajian
- Nashville, TN33 kajian
- Pittsburgh, PA31 kajian
- Boston, MA26 kajian
- Philadelphia, PA23 kajian
- San Francisco, CA22 kajian
- Durham, NC21 kajian
- Atlanta, GA21 kajian
- St. Louis, MO21 kajian
- Salt Lake City, UT21 kajian
Kajian lain di Edison
- Kanser Payudara68 kajian
- Kanser Paru-paru Bukan Sel Kecil47 kajian
- Kanser (semua jenis)33 kajian
- Kanser Prostat29 kajian
- Kanser Kolorektal23 kajian
- Kanser Paru-paru23 kajian
- Mieloma Pelbagai22 kajian
- Kanser Pundi Kencing21 kajian
- Kanser Metastatik20 kajian
- Kanser Ovari20 kajian
- Leukemia Mieloid Akut20 kajian
- Kanser Endometrium19 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.